CTOs on the Move

Epica International, Inc.

www.epicainternational.com

 
Epica International is comprised of three primary business units – CT Imaging & Therapeutics, Medical Robotics and Industrial Robotics.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Epica International, Inc. raised $12.2M on 07/31/2018

Similar Companies

Keir Surgical

Keir Surgical is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Precision Optics

Precision Optics Corporation has been a developer and manufacturer of advanced optical instruments since 1982. We design and produce high-quality medical instruments, micro optics and assemblies with sizes less than 1 millimeter, and other advanced optical systems. Our medical instrumentation line includes rigid laparoscopes, arthroscopes, sinuscopes, and a line of world-class 3-D endoscopes. We also design and build flexible fiber scopes with diameters as small as 5 microns with illumination for use in minimally invasive surgical procedures. We have a complete line of endocouplers with focal ranges from 20mm - 45mm and a parfocal zoom coupler with focal ranges from 20mm-37mm. We are registered to the ISO 9001:2008, ISO 13485:2003, CMDCAS Quality Standards, and comply with the FDA Good Manufacturing Practices and the European Union Medical Device Directive for CE marking of our medical products.

Athena Feminine Technologies

Athena Feminine Technologies is a Orinda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Grapevine Executive Recruiters

Grapevine Executive Recruiters is a Outremont, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Impel NeuroPharma

Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.